|
|
|
Insider
Information: |
Mclaughlin Kevin F |
Relationship: |
Director |
City: |
Waltham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
11,900 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$573,342 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
11,900 |
|
|
Total
Value |
$573,342 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Acceleron Pharma Inc |
XLRN |
SVP, CFO and Treasurer |
2021-11-19 |
0 |
2014-05-19 |
0 |
Premium* |
|
Vericel Corp |
VCEL |
|
2024-05-01 |
11,900 |
2020-04-29 |
0 |
Premium* |
|
Decibel Therapeutics, Inc. |
DBTX |
Director |
2023-09-25 |
0 |
2023-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
101 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2015-03-09 |
4 |
AS |
$40.14 |
$261,647 |
D/D |
(6,500) |
25,000 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2015-01-12 |
4 |
AS |
$40.38 |
$81,318 |
D/D |
(2,000) |
25,000 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2021-09-24 |
4 |
OE |
$40.61 |
$218,251 |
D/D |
5,370 |
16,051 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-04-09 |
4 |
OE |
$41.20 |
$709,711 |
D/D |
17,226 |
28,442 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-12-11 |
4 |
OE |
$41.20 |
$127,720 |
D/D |
3,100 |
14,316 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2019-01-02 |
4 |
AS |
$42.37 |
$244,494 |
D/D |
(5,712) |
38,227 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-01-02 |
4 |
AS |
$42.42 |
$169,680 |
D/D |
(4,000) |
45,300 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-01-04 |
4 |
AS |
$43.00 |
$645,168 |
D/D |
(15,000) |
42,801 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2019-04-09 |
4 |
AS |
$44.61 |
$535,405 |
D/D |
(12,000) |
30,279 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2019-09-10 |
4 |
AS |
$45.29 |
$362,400 |
D/D |
(8,000) |
22,279 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-06-29 |
4 |
AS |
$47.00 |
$1,200,000 |
D/D |
(25,000) |
43,939 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2019-04-02 |
4 |
AS |
$48.02 |
$31,117 |
D/D |
(648) |
42,279 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2019-12-13 |
4 |
AS |
$50.28 |
$595,969 |
D/D |
(11,853) |
10,426 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-01-02 |
4 |
AS |
$52.49 |
$292,923 |
D/D |
(5,579) |
4,847 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-08-30 |
4 |
AS |
$54.00 |
$675,000 |
D/D |
(12,500) |
43,939 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-04-08 |
4 |
AS |
$82.83 |
$3,144,614 |
D/D |
(36,774) |
11,216 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-04-09 |
4 |
AS |
$88.19 |
$1,519,161 |
D/D |
(17,226) |
11,216 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2021-01-05 |
4 |
AS |
$120.43 |
$181,982 |
D/D |
(1,499) |
5,813 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2021-01-04 |
4 |
AS |
$123.49 |
$406,992 |
D/D |
(3,280) |
7,312 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2021-01-04 |
4 |
D |
$124.31 |
$77,569 |
D/D |
(624) |
10,592 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-12-11 |
4 |
AS |
$125.00 |
$387,500 |
D/D |
(3,100) |
11,216 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-12-09 |
4 |
AS |
$125.03 |
$484,116 |
D/D |
(3,872) |
11,216 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-12-10 |
4 |
AS |
$125.12 |
$62,560 |
D/D |
(500) |
11,216 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-12-14 |
4 |
AS |
$130.14 |
$5,534,594 |
D/D |
(42,528) |
11,216 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2021-09-23 |
4 |
AS |
$160.26 |
$3,146,887 |
D/D |
(19,630) |
10,681 |
0 |
% |
|
101 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|